Theriva biologics to participate in the emerging growth conference

Rockville, md., sept. 28, 2023 (globe newswire) -- theriva biologics (nyse american: tovx), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that company's management will provide a corporate update and participate in one-on-one investor meetings at the emerging growth conference, to be held virtually from october 4-5, 2023.
TOVX Ratings Summary
TOVX Quant Ranking